IP Newsflash - hourly updated patent news

IP Newsflash


login| register | newsletter | help | about | disclaimer
Tuesday 21st May 2013 06:02:51 AM MET

EP Monitor - Settings

patents, trademarks, patente, marken
publication type
date range
main class
subclasses
C01B73 hits
NON-METALLIC ELEMENTS
C01F12 hits
COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
C01G18 hits
COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES OR
C02F47 hits
TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
C03B21 hits
MANUFACTURE, SHAPING, OR SUPPLEMENTARY PROCESSES
C03C22 hits
CHEMICAL COMPOSITION OF GLASSES, GLAZES, OR VITREOUS ENAMELS
C04B60 hits
LIME
C05F5 hits
ORGANIC FERTILISERS NOT COVERED BY SUBCLASSES , , e.g. FERTILISERS FROM WASTE OR REFUSE
C06B2 hits
EXPLOSIVE OR THERMIC COMPOSITIONS
C06C2 hits
DETONATING OR PRIMING DEVICES
C06D1 hits
MEANS FOR GENERATING SMOKE OR MIST
C07B15 hits
GENERAL METHODS OF ORGANIC CHEMISTRY
C07C100 hits
ACYCLIC OR CARBOCYCLIC COMPOUNDS
C07D170 hits
HETEROCYCLIC COMPOUNDS
C07F36 hits
ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM
C07H35 hits
SUGARS
C07J3 hits
STEROIDS
C07K177 hits
PEPTIDES
C08B16 hits
POLYSACCHARIDES
C08C5 hits
TREATMENT OR CHEMICAL MODIFICATION OF RUBBERS
C08F62 hits
MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
C08G89 hits
MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
C08H2 hits
DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
C08J79 hits
WORKING-UP
C08K88 hits
USE OF INORGANIC OR NON-MACROMOLECULAR ORGANIC SUBSTANCES AS COMPOUNDING INGREDIENTS
C08L140 hits
COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
C09B5 hits
ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES
C09C14 hits
TREATMENT OF INORGANIC MATERIALS, OTHER THAN FIBROUS FILLERS, TO ENHANCE THEIR PIGMENTING OR FILLING PROPERTIES
C09D80 hits
COATING COMPOSITIONS, e.g. PAINTS, VARNISHES, LACQUERS
C09J29 hits
ADHESIVES
C09K79 hits
MATERIALS FOR APPLICATIONS NOT OTHERWISE PROVIDED FOR
C10B5 hits
DESTRUCTIVE DISTILLATION OF CARBONACEOUS MATERIALS FOR PRODUCTION OF GAS, COKE, TAR, OR SIMILAR MATERIALS
C10G14 hits
CRACKING HYDROCARBON OILS
C10J8 hits
PRODUCTION OF PRODUCER GAS, WATER-GAS, SYNTHESIS GAS FROM SOLID CARBONACEOUS MATERIAL, OR MIXTURES CONTAINING THESE GASES
C10K1 hits
PURIFYING OR MODIFYING THE CHEMICAL COMPOSITION OF COMBUSTIBLE GASES CONTAINING CARBON MONOXIDE
C10L18 hits
FUELS NOT OTHERWISE PROVIDED FOR
C10M14 hits
LUBRICATING COMPOSITIONS
C10N12 hits
LUBRICATING COMPOSITIONS
C11B4 hits
PRODUCING (pressing, extraction), REFINING OR PRESERVING FATS, FATTY SUBSTANCES (e.g. lanolin), FATTY OILS OR WAXES, INCLUDING EXTRACTION FROM WASTE MATERIALS
C11C3 hits
FATTY ACIDS FROM FATS, OILS OR WAXES
C11D17 hits
DETERGENT COMPOSITIONS
C12C2 hits
BREWING OF BEER
C12F1 hits
RECOVERY OF BY-PRODUCTS OF FERMENTED SOLUTIONS
C12G2 hits
WINE
C12M19 hits
APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY
C12N253 hits
MICRO-ORGANISMS OR ENZYMES
C12P51 hits
FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
C12Q97 hits
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS
C12R5 hits
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS
C13B1 hits
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS
C14B2 hits
MECHANICAL TREATMENT OR PROCESSING OF SKINS, HIDES, OR LEATHER IN GENERAL
C14C1 hits
CHEMICAL TREATMENT OF HIDES, SKINS OR LEATHER, e.g. TANNING, IMPREGNATING, FINISHING
C21B4 hits
MANUFACTURE OF IRON OR STEEL
C21C3 hits
PROCESSING OF PIG-IRON, e.g. REFINING, MANUFACTURE OF WROUGHT-IRON OR STEEL
C21D43 hits
MODIFYING THE PHYSICAL STRUCTURE OF FERROUS METALS
C22B13 hits
PRODUCTION OR REFINING OF METALS
C22C68 hits
ALLOYS
C22F20 hits
CHANGING THE PHYSICAL STRUCTURE OF NON-FERROUS METALS OR NON-FERROUS ALLOYS
C23C84 hits
COATING METALLIC MATERIAL
C23D1 hits
ENAMELLING OF, OR APPLYING A VITREOUS LAYER TO, METALS
C23F5 hits
NON-MECHANICAL REMOVAL OF METALLIC MATERIAL FROM SURFACES
C23G3 hits
CLEANING OR DE-GREASING OF METALLIC MATERIAL BY CHEMICAL METHODS OTHER THAN ELECTROLYSIS
C25B8 hits
ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON- METALS
C25C1 hits
PROCESSES FOR THE ELECTROLYTIC PRODUCTION, RECOVERY OR REFINING OF METALS
C25D17 hits
PROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS
C25F1 hits
PROCESSES FOR THE ELECTROLYTIC REMOVAL OF MATERIALS FROM OBJECTS
C30B17 hits
SINGLE-CRYSTAL GROWTH
C40B3 hits
COMBINATORIAL CHEMISTRY

Results (C12N)

patents, trademarks, patente, marken
This search has been performed for all patent publications within the last 6 months in class C12N (MICRO-ORGANISMS OR ENZYMES).
EP2520657A32013-01-02
Modification of plant lignin content
EP2497376A32013-01-02
Stable, durable granules with active agents
EP2447367A32013-01-02
Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
EP2444810A32013-01-02
Proteases mutants with altered specificity and uses thereof
EP2444809A32013-01-02
Methods of generating and screening for proteases with altered specificity
EP2399988A32013-01-02
Cell culture system for replication of HCV through the farnesoid X receptor (FXR) activation or inhibition and diagnostic method for HCV infection
EP2465924A32013-01-02
Isolated cells and populations comprising same for the treament of cns diseases
EP2163613A32013-01-02
Method for manufacturing organic chemical compounds using improved strains of the enterobacteriaceae family
EP2540831A22013-01-02
Transgenic plants with enhanced agronomic traits
EP2540740A22013-01-02
Multimeric TNF receptors
EP2540830A22013-01-02
Tobacco plants having reduced nicotine demethylase activity
EP2540825A22013-01-02
Cleaning compositions comprising amylase variants reference to a sequence listing
EP2540815A12013-01-02
Perfusion cell culture
EP2540314A12013-01-02
Raccoon poxvirus expressing rabies glycoproteins
EP2540312A12013-01-02
Avian influenza chimeric VLPS
EP2540832A12013-01-02
Plants transformed with a small inducible kinase having improved yield related traits and a method for making the same
EP2540818A12013-01-02
Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof
EP2540313A12013-01-02
Adaptation of pitman moore strain of rabies virus to primary chick embryo fibroblast cell cultures
EP2540820A12013-01-02
Means and methods for influencing the stability of antibody producing cells
EP2540817A12013-01-02
Methods and recombinant microbial hosts for the production of isobutanol
EP2540389A12013-01-02
Method of encapsulating a molecule and a microbead
EP2540823A12013-01-02
Novel restriction endonucleases, DNA encoding these endonucleases and methods for identifying new endonucleases with the same or varied specificity
EP2540827A12013-01-02
ANTI-ICAM3 ANTIBODY AND USE THEREOF
EP2540839A12013-01-02
METHOD FOR DETERMINING PRESENCE OR ABSENCE OF CANCER CELL IN BIOLOGICAL SAMPLE, AND MOLECULAR MARKER AND KIT FOR DETERMINATION
EP2540829A12013-01-02
MARKER FOR DETECTION OF MYOGENIC DISEASES, AND METHOD FOR DETECTION OF THE DISEASES USING SAME
EP2540821A12013-01-02
METHOD FOR PRODUCING REGULATORY DENDRITIC CELLS
EP2540835A12013-01-02
PROCESS FOR PRODUCTION OF POLYHYDROXYALKANOIC ACID USING GENETICALLY MODIFIED MICROORGANISM HAVING ENOYL-CoA HYDRATASE GENE INTRODUCED THEREIN
EP2540836A12013-01-02
PROCESS FOR PRODUCTION OF CADAVERINE
EP2540816A12013-01-02
METHOD FOR CONSTRUCTING NOVEL BACTERIUM BELONGING TO THE GENUS BIFIDOBACTERIUM
EP2540826A12013-01-02
METHOD FOR PRODUCING GLUCURONIC ACID CONJUGATE USING SACCHAROMYCES CEREVISIAE
EP2540838A12013-01-02
KIT FOR QUANTITATIVE DETECTION OF BRAF MUTATION
EP2540822A12013-01-02
METHOD FOR IDENTIFICATION OF ONCOGENE, METHOD FOR ESTABLISHMENT OF CELL CAPABLE OF EXPRESSING ONCOGENE, AND METHOD FOR SCREENING FOR ONCOGENE-TARGETING SUBSTANCE
EP2540834A12013-01-02
Method for the preparation of 1,3-propanediol
EP2540824A12013-01-02
Cleaning compositions comprising amylase variants reference to a sequence listing
EP2540828A12013-01-02
Composition comprising inhibitors of IRS-1 and of VEGF
EP2540819A12013-01-02
Method for cultivating cells in platelet-lysate-containing medium
EP2540744A12013-01-02
FULLY HUMAN MONOCLONAL ANTIBODY TO VEGF, PREPARATION METHOD AND USE THEREOF
EP2540745A12013-01-02
FULLY HUMANIZED ANTI-HER2 ANTIBODY, PREPARATION METHOD AND USE THEREOF
EP2540806A12013-01-02
METHOD AND SYSTEM FOR PRODUCING A SOURCE OF THERMODYNAMIC ENERGY BY CO2 CONVERSION FROM CARBON-CONTAINING RAW MATERIALS
EP2468860A92012-12-26
TRANSFORMANT AND PROCESS FOR PRODUCTION THEREOF, AND PROCESS FOR PRODUCTION OF LACTIC ACID
EP2453017A92012-12-26
Oligonucleotides for use in prophylaxis and/or treatment of TGF-beta1 and TGF-beta2, TGF-beta2 and TGF-beta3, TGF-beta1 and TGF-beta3, or TGF-beta1, TGF-beta2, and TGF-beta3 mRNA overexpressing diseases
EP2520655A32012-12-26
Transgenic plants with increased stress tolerance and yield
EP2455460A32012-12-26
Lipase variants for pharmaceutical use
EP2474557A32012-12-26
Anti-CD79b antibodies and immunoconjugates and methods of use
EP2500428A32012-12-26
Nucleic acid construct systems capable of diagnosing or treating a cell state
EP2463374A32012-12-26
Isolated alcohol dehydrogenase enzymes and uses thereof
EP2447368A32012-12-26
Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
EP2194129A32012-12-26
Pharmaceutical composition comprising anti-miRNA antisense oligonucleotides
EP2537940A22012-12-26
Plants having increased yield-related traits and a method for making the same
EP2537935A22012-12-26
Modified microorganism for high efficient production of lactic acid
EP2537938A22012-12-26
Physcomitrella patents genes which improve stress tolerance
EP2537934A22012-12-26
Methods of regulating expression of genes or of gene products using substituted tetracycline compounds
EP2537924A22012-12-26
MEK ligands and polynucleotides encoding mek ligands
EP2537937A22012-12-26
Genes and uses for plant enhancement
EP2537922A22012-12-26
CD49F PROMOTING PROLIFERATION, MULTIPOTENCY AND REPROGRAMMING OF ADULT STEM CELLS THROUGH PI3K/AKT/GSK3 PATHWAY
EP2537522A12012-12-26
Neuronal progenitor cells and methods of derivation and purification of neuronal progenitor cells from embryonic stem cells
EP2537939A12012-12-26
Tobacco plants having reduced nicotine demethylase activity
EP2537921A12012-12-26
Novel cell culture method and methods of producing and collecting cell masses using the same
EP2537528A12012-12-26
Pharmaceutical or nutritional compositions containing galactosidase, and their use
EP2537925A12012-12-26
Novel restriction endonucleases, DNA encoding these endonucleases, and methods for identifying new endonucleases with the same or varied specificity
EP2537932A12012-12-26
Compositions for and methods of identifying antigens
EP2537931A12012-12-26
ANTIVIRAL AGENT, ABZYME, PRIMER SET, METHOD FOR PRODUCING POLYNUCLEOTIDE, AND METHOD FOR PRODUCING POLYPEPTIDE
EP2537930A12012-12-26
METHOD FOR PRODUCING INDUCED PLURIPOTENT STEM CELLS
EP2537929A12012-12-26
PLANT COMPONENT REGULATION FACTOR, AND USE THEREOF
EP2537825A12012-12-26
METHOD FOR PRODUCING 1-AMINO-1-ALKOXYCARBONYL-2-VINYLCYCLOPROPANE
EP2537920A12012-12-26
METHOD FOR PRODUCTION OF ARTIFICIAL PLURIPOTENT STEM CELL
EP2537928A12012-12-26
NOVEL PROMOTER FOR USE IN TRANSFORMATION OF ALGAE
EP2537941A12012-12-26
METHODS AND NUCLEOTIDE FRAGMENTS OF PREDICTING THE ABILITY OF TUMOR INVASION AND METASTASIS IN VITRO
EP2537927A12012-12-26
POLYNUCLEOTIDE ENCODING ACYL-COA SYNTHETASE HOMOLOG AND METHOD FOR USING THE SAME
EP2537933A12012-12-26
An IL-15 and IL-15Ralpha sushi domain based immunocytokines
EP2537936A12012-12-26
P0 gene silencing constructs and use
EP2537926A12012-12-26
Valencene synthase
EP2537923A12012-12-26
Method for activation of specific peripheral blood mononuclear cells
EP2537523A12012-12-26
PROPHYLACTIC/AMELIORATING AGENT FOR DISEASES, ENDURANCE IMPROVING AGENT AND ANTI-FATIGUE AGENT, AND PHARMACEUTICAL AGENT, FOOD AND BEVERAGE EACH COMPRISING ANY ONE OF THOSE AGENTS
EP2460880A92012-12-19
MARKER AND REAGENT FOR DETECTION OF HUMAN IL-17-PRODUCING HELPER T CELLS, AND METHOD FOR DETECTION OF HUMAN IL-17-PRODUCING HELPER T CELLS
EP2527369A32012-12-19
Monoclonal amyloid beta (abeta)-specific antibody and uses thereof
EP2500432A32012-12-19
Analogues of human pancreatic polypeptide (hPP) and their effects on feeding behaviours
EP2502996A32012-12-19
Anti-FGF23 antibody and pharmaceutical composition comprising the same
EP2502494A32012-12-19
Novel alpha-galactosidases
EP2502493A32012-12-19
Novel alpha-galactosidases
EP2502492A32012-12-19
Novel alpha-galactosidases
EP2502491A32012-12-19
Novel alpha-galactosidases
EP2500422A32012-12-19
Nucleic acid molecules encoding polypeptides involved in regulation of sugar and lipid metabolism and methods of use VIII
EP2494993A32012-12-19
Amino acid lipids and uses thereof
EP2476692A32012-12-19
Peptide vaccines for cancers expressing tumor-associated antigens
EP2399575A32012-12-19
Methods, uses and compositions for treatment of an infection by a virus of the family of flaviviridae through the farnesoid X receptor (FXR) inhibition
EP2395017A32012-12-19
Design and use of paired variable regions of specific binding molecules
EP2395016A32012-12-19
Design and use of paired variable regions of specific binding molecules
EP2292264A32012-12-19
Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compounds
EP2292770A32012-12-19
Methods and means for producing proteins with predetermined post-translational modifications
EP2314689A32012-12-19
Antisense compounds targeted to connexins and methods of use thereof
EP2163542A32012-12-19
Bi-functional compound positively charged at first pH and negatively charged at second pH, solid support comprising the bi-functional compound, and method of isolating nucleic acid using the same
EP2535355A22012-12-19
Antibodies against CD38 for treatment of multiple myeloma
EP2535058A22012-12-19
Stabilization of vaccines by lyophilization
EP2535413A22012-12-19
Splice switching oligomers for the TNF superfamily receptors and their use in treatment of disease
EP2535414A12012-12-19
Novel glyphosate-n-acetyltransferase (gat) genes
EP2535418A12012-12-19
Mammalian-type glycosylation in plants by expression of non-mammalian glycosyltransferases
EP2534951A12012-12-19
Combating pests with a combination of insecticides and transgenic plants by means of leaf and drench application
EP2535406A12012-12-19
Meganuclease variants cleaving a DNA target sequence from the human hemoglobin beta gene and uses thereof
EP2535417A12012-12-19
Plants having increased yield-related traits and a method for making the same
EP2535416A12012-12-19
Development of phytophthora resistant potato with increased yield
EP2535403A12012-12-19
Very small embryonic-like (VSEL) stem cells and methods of isolating and using the same
EP2535346A12012-12-19
Cellular libraries of peptide sequences (CLiPS) and methods of using the same
EP2535410A12012-12-19
APTAMER TO FGF2 AND USE THEREOF
EP2535409A12012-12-19
METHOD FOR PRODUCING RECOMBINANT VIRUS
EP2535404A12012-12-19
METHOD FOR ACQUIRING GENETICALLY IDENTICAL GAMETE FROM LETHAL FISH HAPLOID-DERIVED GERM CELL VIA GERM LINE CHIMERA
EP2535358A12012-12-19
RADIOACTIVE METAL-LABELED ANTI-CADHERIN ANTIBODY
EP2534964A12012-12-19
ENZYMATIC TREATMENT SOLUTION, SOFTENING METHOD, AND SOFTENED ANIMAL-BASED FOOD PRODUCT
EP2535408A12012-12-19
MICROCHIP FOR NUCLEIC ACID AMPLIFICATION REACTION AND AND PROCESS FOR PRODUCTION THEREOF
EP2535348A12012-12-19
APPLICATIONS OF THE PROTEIN MUNS AND THE DERIVATES THEREOF
EP2535407A12012-12-19
MANUFACTURING METHOD FOR MUTANT rpsA GENE AND L-AMINO ACID
EP2535052A12012-12-19
METHOD FOR PRODUCING NK CELL ENHANCEMENT-TYPE BLOOD PRODUCT
EP2535412A12012-12-19
New treatment for muscular dystrophies
EP2535151A12012-12-19
Actuator apparatus with control device
EP2535411A12012-12-19
PROBE FOR HPV GENOTYPE DIAGNOSIS AND ANALYSIS METHOD THEREOF
EP2535415A12012-12-19
MODIFIED NUCLEOTIDE MOLECULES OF XYLANASE AND APPLICATION THEREOF
EP2535405A12012-12-19
A RECOMBINANT A/ASTANARG/6:2/2009 M-12-09/D FLU VIRUS STRAIN PRODUCED BY A REVERSE GENETICS METHOD FROM A HIGHLY PATHOGENIC DONOR STRAIN A/CHICKEN/ASTANA/6/05 (H5N1) AND A HIGHLY REPRODUCTIVE DONOR STRAIN A/PUERTO RICO/8/34 (H1N1) FROM THE ORTHOMYXOVIRIDAE FAMILY OF THE GENUS INFLUENZA VIRUS TYPE A WHICH IS DEPOSITED IN THE MICROORGANISM COLLECTION OF THE SCIENCE COMMITTEE AT THE MINISTRY OF EDUCATION AND SCIENCE OF THE REPUBLIC OF KAZAKHSTAN STATE ENTERPRISE SUBSIDIARY OF THE SCIENTIFIC RESEARCH INSTITUTE FOR BIOLOGICAL SAFETY PROBLEMS AT THE REPUBLICAN STATE ENTERPRISE OF THE NATIONAL CENTRE FOR BIOTECHNOLOGY OF THE REPUBLIC OF KAZAKHSTAN AND CAN BE USED IN BIOTECHNOLOGY FOR THE PRODUCTION OF DIAGNOSTIC AND VACCINE PREPARATIONS AGAINST A/H5N1 FLU
EP2527452A32012-12-12
Chloroplast transit peptides for efficient targeting of DMO and uses thereof
EP2522722A32012-12-12
Nucleic acid molecules encoding polypeptides involved in regulation of sugar and lipid metabolism and methods of use VIII
EP2492345A32012-12-12
Seed enhancement by combinations of pyruvate kinases
EP2471911A32012-12-12
Fungal peroxygenases and methods of application
EP2500423A32012-12-12
Amylases producing an altered immunogenic response and methods of making and using the same
EP2476695A32012-12-12
Peptide vaccines for cancers expressing tumor-associated antigens
EP2428572A32012-12-12
Alkaliphilic Bacillus species alpha-amylase variants, compositions comprising alpha-amylase variants, and methods of use
EP2497778A32012-12-12
Manipulation of the nitrogen metabolism
EP2311955A32012-12-12
Osteoprotegerin binding proteins and their receptors
EP2292762A32012-12-12
VMP-like sequences of pathogenic Borrelia species and strains
EP2532745A22012-12-12
Method and Compositions for Detection and Enumeration of Genetic Variations
EP2532746A22012-12-12
Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells
EP2532737A22012-12-12
Cell culture improvements
EP2532739A22012-12-12
Method of screening candidate compounds for susceptibility to biliary excretion
EP2532748A22012-12-12
DNA aptamer specifically binding to human cardiac troponin I
EP2532750A12012-12-12
Herbicide-resistant sunflower plants, polynucleotides encoding herbicide-resistant acetohydroxyacid synthase large subunit proteins, and methods of use
EP2532362A12012-12-12
Vaccines including antigen from four strains of influenza virus
EP2532675A12012-12-12
Long-acting polypeptides and methods of producing and administering same
EP2532674A12012-12-12
Long-acting polypeptides and methods of producing and administering same
EP2532742A12012-12-12
Production and purification of recombinant arylsulfatase A
EP2532241A12012-12-12
Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
EP2532681A12012-12-12
Anti-ILT7 antibody
EP2532749A12012-12-12
DNA aptamer specifically binding to pLDH (Plasmodium Lactacte Dehydrogenase)
EP2532738A12012-12-12
METHOD FOR CULTURE OF CORNEAL ENDOTHELIAL CELLS, PROCESS FOR PRODUCTION OF CORNEAL ENDOTHELIAL CELL SHEET FOR TRANSPLANTATION PURPOSES, AND CULTURE KIT FOR CORNEAL ENDOTHELIAL CELLS
EP2532743A12012-12-12
PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF CANCER
EP2532680A12012-12-12
MEDICINAL COMPOSITION FOR TREATING AND/OR PREVENTING CANCER
EP2532744A12012-12-12
GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE HOMOLOGUE AND USE THEREOF
EP2532741A12012-12-12
INDUCED HEPATIC STEM CELL AND PROCESS FOR PRODUCTION THEREOF, AND APPLICATIONS OF THE CELL
EP2532734A12012-12-12
METHOD FOR PRODUCING INTERFERON ALPHA 5
EP2532733A12012-12-12
A method for enhancing the fermentative poteltial and growth rate of microorganisms under anaerobiosis
EP2532751A12012-12-12
Use of inducible promoters in the fermentative production of 1,2-propanediol
EP2532740A12012-12-12
Antigen-specific CD4+ and CD8+ central-memory T cell preparations for adoptive T cell therapy
EP2532736A12012-12-12
Engineered living tissue substitute
EP2532735A12012-12-12
Identifying optimal topography to control cellular function and neo-tissue formation
EP2532704A12012-12-12
Coated polymer system and methods for its production
EP2532433A12012-12-12
DEVICE FOR FRAGMENTING MOLECULES IN A SAMPLE BY ULTRASOUND
EP2532747A12012-12-12
Modulators of ADP-dependent glucokinase (ADPGK) and glycerol-3-phosphate dehydrogenase (GPD2) for therapy
EP2454942A82012-12-05
METHOD FOR IMPROVEMENT OF FOODS UTILIZING BETA-AMYLASE
EP2527439A32012-12-05
Compositions and methods related to mRNA translational enhancer elements
EP2497495A32012-12-05
Making influenza virus vaccines without using eggs
EP2520652A32012-12-05
Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associates genes
EP2380983A32012-12-05
RAGE fusion proteins, formulations, and methods of use thereof
EP2465922A32012-12-05
Mesenchymal stem cells expressing TNF-alpha receptor
EP2354229A32012-12-05
Modulation of 11beta-hydroxysteroid dehydrogenase 1 expression for the treatment of ocular diseases
EP1734050A32012-12-05
Immunization of dairy cattle with GapC protein against streptococcus infection
EP1734119A32012-12-05
CD16-II variants
EP2530161A22012-12-05
Process for producing poxviruses and poxvirus compositions
EP2530147A22012-12-05
Influenza hemagglutinin and neuraminidase variants
EP2530090A22012-12-05
Anti-IL-13R alpha 1 antibodies and their uses thereof
EP2530157A22012-12-05
Oligomeric compounds and compositions for use in modulation of small non-coding rnas
EP2530144A22012-12-05
Composition comprising cell and biocompatible polymer
EP2530087A22012-12-05
Sequences of brachyspira, immunogenic composition, methods for preparation and use thereof
EP2530156A12012-12-05
ENA nucleic acid drugs modifying splicing in mRNA precursor
EP2530155A12012-12-05
ENA nucleic acid drugs modifying splicing in mRNA precursor
EP2530154A12012-12-05
ENA nucleic acid drugs modifying splicing in mRNA precursor
EP2530153A12012-12-05
ENA nucleic acid drugs modifying splicing in mRNA precursor
EP2530092A12012-12-05
Antibody capable of discriminating the change in structure between antibody conjugated with antibody and antibody unconjugated with antibody, and method for production of the antibody
EP2530169A12012-12-05
Transcription factor decoys, compositions and methods
EP2530152A12012-12-05
Reduction of off-target RNA interference toxicity
EP2530146A12012-12-05
Immunomodulation using placental stem cells
EP2530145A12012-12-05
Immunomodulation using placental stem cells
EP2530086A12012-12-05
Processes for packaging oligonucleotides into virus-like particles of RNA bacteriophages
EP2530151A12012-12-05
TRANSFORMATION PLASMID
EP2530150A12012-12-05
TRANSFORMATION PLASMID
EP2530141A12012-12-05
MICROORGANISM CULTURE SHEET
EP2530142A12012-12-05
PERFUSION CULTURE METHOD AND PERFUSION CULTURE DEVICE FOR ORGAN OR TISSUE
EP2530165A12012-12-05
METHOD FOR PRODUCING PYRIPYROPENE DERIVATIVE BY ENZYMATIC PROCESS
EP2530149A12012-12-05
NUCLEIC ACID STRUCTURE CONTAINING A PYRIPYROPENE BIOSYNTHESIS GENE CLUSTER AND A MARKER GENE
EP2530164A12012-12-05
METHOD FOR MANUFACTURING A PYRIPYROPENE
EP2530091A12012-12-05
ANTI-DLL3 ANTIBODY
EP2530143A12012-12-05
METHOD FOR THE IDENTIFICATION AND PURIFICATION OF HUMAN NATURALLY OCCURRING REGULATORY T CELLS (NTREGS)
EP2530158A12012-12-05
GENES ENCODING PROTEINS ABLE TO ENHANCE HEAT RESISTANCE OF PLANTS AND MICROORGANISM AND USES THEREOF
EP2530162A12012-12-05
Biomolecule surface display and uses thereof
EP2530159A12012-12-05
Transcription terminator sequences
EP2530163A12012-12-05
Double marker cell line
EP2530160A12012-12-05
Means and methods to induce apomixis in plants
EP2530148A12012-12-05
Novel beta-galactosidases useful for the production of lactose depleted milk products
EP2453013A92012-11-28
Treatment of cellulosic material and enzymes useful therein
EP2463368A92012-11-28
HUMANIZED ANTI-AMYLOID-B OLIGOMER ANTIBODY
EP2463367A92012-11-28
NOVEL UBIQUITIN LIGASE AND USE THEREOF
EP2505655A32012-11-28
Recombinat yeast strains expressing tethered cellulase enzymes
EP2511287A32012-11-28
Gene knockout mesophilic and thermophilic organisms, and methods of use thereof
EP2511286A32012-11-28
Gene knockout mesophilic and thermophilic organisms, and methods of use thereof
EP2511285A32012-11-28
Gene knockout mesophilic and thermophilic organisms, and methods of use thereof
EP2511284A32012-11-28
Gene knockout mesophilic and thermophilic organisms, and methods of use thereof
EP2487262A32012-11-28
MicroRNA-based Methods and Compositions for the Diagnosis and Treatment of Solid Cancers
EP2489726A32012-11-28
Genes and uses for plant improvement
EP2508614A32012-11-28
Glycosylation of molecules
EP2508613A32012-11-28
Glycosylation of molecules
EP2402463A32012-11-28
Nucleic acid molecules and collections thereof, their application and identification
EP2390334A32012-11-28
Expression system
EP2386644A32012-11-28
Expression system
EP2386643A32012-11-28
Expression system
EP2327784A32012-11-28
Nucleic acids for inhibiting hairless protein expression and methods of use thereof
EP2369001A32012-11-28
PRRS viruses, infectious clones, mutants thereof, and methods of use
EP2314693A32012-11-28
Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
EP2527439A22012-11-28
Compositions and methods related to mRNA translational enhancer elements
EP2527445A22012-11-28
Treatment and prevention of influenza
EP2527455A22012-11-28
Vegetabile material, plants and a method of producing a plant having altered lignin properties
EP2527453A22012-11-28
Chloroplast transit peptides for efficient targeting of DMO and uses thereof
EP2527452A22012-11-28
Chloroplast transit peptides for efficient targeting of DMO and uses thereof
EP2527430A22012-11-28
Method of preparing a dough-based product
EP2527444A22012-11-28
Antisense oligonucleotide modulation of stat3 expression
EP2527443A22012-11-28
RNAi-mediated inhibition of IGF-1R for treatment of ocular angiogenesis
EP2527442A22012-11-28
Compounds and methods for modulating gene expression
EP2527441A22012-11-28
Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis
EP2527427A22012-11-28
Multipotent postnatal stem cells from human periodontal ligament and uses thereof
EP2526966A22012-11-28
Herpes simplex virus combined subunit vaccines and methods of use thereof
EP2527435A22012-11-28
Methods and compositions for inactivating alpha 1,6 fucosyltransferase (FUT 8) gene expression
EP2527429A22012-11-28
DAC HYP compositions and methods
EP2526968A22012-11-28
Nogo receptor antagonists
EP2527454A12012-11-28
Vegetabile material, plants and a method of producing a plant having altered lignin properties
EP2527457A12012-11-28
Widespread gene delivery to motor neurons using peripheral injection of AAV vectors
EP2527362A12012-11-28
Nucleic acid molecules encoding wrinkled1-like polypeptides and methods of use in plants
EP2527447A12012-11-28
Agents and methods for diagnosing stress
EP2527446A12012-11-28
Agents and methods for diagnosing stress
EP2527426A12012-11-28
Isolation, characterization and propagation of germline stem cells
EP2527451A12012-11-28
Screening method for identifying genes involved in plant cell cycle
EP2527450A12012-11-28
Plant root-specific nematode resistance
EP2527425A12012-11-28
Cell culture improvements
EP2527437A12012-11-28
Novel anti-CD98 antibody
EP2527367A12012-11-28
Production method
EP2527438A12012-11-28
Methods and compositions for DNA fragmentation and tagging by transposases
EP2527366A12012-11-28
Monoclonal anti beta amyloid antibody
EP2527354A12012-11-28
Compositions and methods for inhibiting expression of Eg5 gene
EP2527456A12012-11-28
Transgenic porcines lacking endogenous immunoglobulin light chain
EP2527434A12012-11-28
PROBE REAGENT FOR MEASUREMENT OF PROTEIN DECOMPOSITION ACTIVITY
EP2527436A12012-11-28
NADH OXIDASE MUTANT HAVING IMPROVED STABILITY AND USE THEREOF
EP2527433A12012-11-28
FOREIGN GENE TRANSFER METHOD BY ELECTROPORATION TECHNIQUE
EP2527428A12012-11-28
Tolerogenic dendritic cells and their use in cell therapy
EP2527361A12012-11-28
Biomarkers for in vitro prognosis and diagnosis of graft and transplant rejection
EP2527440A12012-11-28
Cancer treatment by combining DNA molecules mimicking double strand breaks with hyperthermia
EP2527424A12012-11-28
Recombinant expression of soluble Interferon
EP2527448A12012-11-28
Simultaneous site-specific integrations of multiple gene-copies in filamentous fungi
EP2527432A12012-11-28
Bi-directional cytosine deaminase-encoding selection marker
EP2527431A12012-11-28
Novel Listeria bacteriophage tailspike protein and uses thereof

Details

patents, trademarks, patente, marken close
Title:PRODUCTION METHOD FOR 1,3-PROPANEDIOL USING RECOMBINANT MICROBIAL STRAIN HAVING GLYCEROL OXIDATION METABOLIC PATHWAY BLOCKED
Applicants:KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
Inventors:KIM, Chul-Ho; SEO, Jeong-Woo; OH, Baek Rock; HEO, Sun-Yeon; SEO, Mi Young; CHOI, Min Ho
Main IPC Subclass:C12N 15/52; C12N 1/21; C12P 7/18; C12N 15/63
Agent:Hiebl, Inge Elisabeth
Application:2009-03-12 as 09841538.3
Publication:2012-01-18 as EP2407544A1
Patent FamilyFull TextRegister & FilePDF

Monitor C12N

patents, trademarks, patente, marken
Add IP Newsflash to My Yahoo!Add IP Newsflash to NewsgatorAdd IP Newsflash to PluckAdd IP Newsflash to RojoAdd IP Newsflash to BloglinesAdd IP Newsflash to GoogleAdd this feed to your favorite feed reader by clicking on one of these buttons to be automatically reminded of new publications in this class.

You may also install an email alert for this class:
Email:

Top Applicants (C12N)

patents, trademarks, patente, marken
1. 9BASF PLANT SCIENCE GMBH
2. 5MONSANTO TECHNOLOGY LLC
3. 5NOVOZYMES A/S
4. 4TAKESHIMA, YASUHIRO
5. 4NONPROFIT ORGANIZATION TRANSLATIONAL RESEARCH ORGANIZATION OF DUCHENNE MUSCULAR DYSTROPHY
6. 4MASCOMA CORP.
7. 4VELICO MEDICAL, INC.
8. 4MATSUO, MASAFUMI
9. 4KNC LABORATORIES CO., LTD
10. 3TORAY INDUSTRIES, INC.
11. 3UNIVERSITEIT GENT
12. 3MEIJI SEIKA PHARMA CO., LTD.
13. 3FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LTD.
14. 3KYOWA HAKKO KIRIN CO., LTD.
15. 3THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
16. 2INIMEX PHARMACEUTICALS INC.
17. 2OSAKA UNIVERSITY
18. 2U.S. SMOKELESS TOBACCO CO. LLC
19. 2UNIVERSIDADE DE SANTIAGO DE COMPOSTELA
20. 2FORERUNNER PHARMA RESEARCH CO., LTD.


Top Applicants (C)

patents, trademarks, patente, marken
1. 22TORAY INDUSTRIES, INC.
2. 19BASF SE
3. 18NITTO DENKO CORP.
4. 18BASF PLANT SCIENCE GMBH
5. 14NOVARTIS AG
6. 14NIPPON STEEL CORP.
7. 13ASAHI GLASS CO., LTD.
8. 12UNITED TECHNOLOGIES CORP.
9. 12DOW GLOBAL TECHNOLOGIES LLC
10. 11BOREALIS AG
11. 11ABBOTT LABORATORIES
12. 11LG CHEM, LTD.
13. 10NOVOZYMES A/S
14. 10MONSANTO TECHNOLOGY LLC
15. 10FUJIFILM CORP.
16. 10SAMSUNG ELECTRONICS CO., LTD.
17. 9KANEKA CORP.
18. 9NATIONAL UNIVERSITY OF IRELAND, GALWAY
19. 9THE PROCTER & GAMBLE CO.
20. 9JFE STEEL CORP.


Top Applicants (overall)

patents, trademarks, patente, marken
1. 244GENERAL ELECTRIC CO.
2. 218SAMSUNG ELECTRONICS CO., LTD.
3. 164LG ELECTRONICS INC.
4. 149PANASONIC CORP.
5. 141ZTE CORP.
6. 138SIEMENS AG
7. 125SONY CORP.
8. 102SHARP K.K.
9. 96MITSUBISHI HEAVY INDUSTRIES, LTD.
10. 96CANON K.K.
11. 94UNITED TECHNOLOGIES CORP.
12. 89TOYOTA JIDOSHA K.K.
13. 83K.K. TOSHIBA
14. 80HUAWEI TECHNOLOGIES CO., LTD.
15. 79RESEARCH IN MOTION LTD.
16. 74ALCATEL LUCENT
17. 67FUJITSU LTD.
18. 63NEC CORP.
19. 59HONEYWELL INTERNATIONAL INC.
20. 58MITSUBISHI ELECTRIC CORP.